Commitments and Contingencies (Details Narrative)
|
|
|
6 Months Ended |
|
|
Nov. 03, 2020 |
Dec. 13, 2019
EUR (€)
shares
|
Dec. 13, 2019
USD ($)
$ / shares
shares
|
Jun. 30, 2021
EUR (€)
|
Jun. 30, 2021
USD ($)
|
Jun. 30, 2021
USD ($)
|
Dec. 31, 2020
USD ($)
|
Total Long-Term Debt |
|
|
|
|
|
$ 3,042,117
|
|
Payments for future research and collobration |
|
|
|
|
|
964,099
|
|
Short term lease costs |
|
|
|
|
$ 37,417
|
|
|
Aggerate amount payable, description |
the Company to pay in aggregate of up to $2.9 million over a period of 22 months.
|
|
|
|
|
|
|
Amount payable |
|
|
|
|
|
308,692
|
|
Operating lease right-of-use assets |
|
|
|
|
|
318,393
|
$ 326,085
|
In 2018 [Member] | Finance Lease Obligations [Member] | BNP Paribas leasing solutions [Member] |
|
|
|
|
|
|
|
Amount payable |
|
|
|
|
|
$ 6,460
|
|
Purchase price for the property | € |
|
|
|
€ 25,000
|
|
|
|
Maturity date |
|
|
|
Jan. 31, 2022
|
Jan. 31, 2022
|
|
|
Implicit interest |
|
|
|
1.35%
|
|
1.35%
|
|
Leased equipment amortized term |
|
|
|
5 years
|
5 years
|
|
|
In 2019 [Member] | Taxes A&M University [Member] |
|
|
|
|
|
|
|
Repayment of long-term loan amount |
|
|
|
|
$ 400,000
|
|
|
Loan agreement term |
|
|
|
5 years
|
5 years
|
|
|
Collaborative obligations amount due |
|
|
|
|
|
$ 122,123
|
|
In 2019 [Member] | Collaborative Arrangement, Co-promotion [Member] |
|
|
|
|
|
|
|
Collaborative obligations amount due |
|
|
|
|
|
0
|
|
Research collaboration agreement description |
|
|
|
Company entered into a research collaboration agreement with the University of Taiwan for a two-year period to collect a total of 1,200 samples for a cost to the Company of up to $320,000 payable over such period.
|
Company entered into a research collaboration agreement with the University of Taiwan for a two-year period to collect a total of 1,200 samples for a cost to the Company of up to $320,000 payable over such period.
|
|
|
January 10, 2020 [Member] |
|
|
|
|
|
|
|
Common stock, restricted shares issued in exchange of purchased outstanding shares, value |
|
|
$ 333,969
|
|
|
|
|
Restricted shares issued | shares |
|
73,263
|
73,263
|
|
|
|
|
Common stock, restricted shares issued in exchange of purchased outstanding shares, shares | shares |
|
73,263
|
73,263
|
|
|
|
|
Weighted trading price per share | $ / shares |
|
|
$ 4.56
|
|
|
|
|
Repayment of debt | € |
|
€ 350,000
|
|
|
|
|
|
Common stock adjusted amount |
|
|
$ 357,000
|
|
|
|
|
Holdback period |
|
|
|
9 months
|
9 months
|
|
|
Holdback liabilities |
|
|
|
|
|
55,404
|
|
Net liabilities |
|
|
$ 43,152
|
|
|
|
|
Walloon Region Government [Member] | In 2020 [Member] |
|
|
|
|
|
|
|
Amount payable |
|
|
|
|
|
$ 61,254
|
|
Terms of agreement description |
|
|
|
The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €148,500 and the 2.89% royalty on revenue, is equal to the amount of funding received.
|
The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €148,500 and the 2.89% royalty on revenue, is equal to the amount of funding received.
|
|
|
Repayment of grants | € |
|
|
|
€ 148,500
|
|
|
|
Grant receivable | € |
|
|
|
€ 495,000
|
|
|
|
Fixed interest rate on lease |
|
|
|
2.89%
|
|
2.89%
|
|
Walloon Region Government [Member] | In 2010 [Member] |
|
|
|
|
|
|
|
Amount payable |
|
|
|
|
|
$ 65,183
|
|
Repayment of long-term loan amount | € |
|
|
|
€ 315,788
|
|
|
|
Terms of agreement description |
|
|
|
it is due to pay a 6% royalty on such revenue to the Walloon Region.
|
it is due to pay a 6% royalty on such revenue to the Walloon Region.
|
|
|
Repayment of grants | € |
|
|
|
€ 314,406
|
|
|
|
Grant receivable | € |
|
|
|
€ 1,050,000.00
|
|
|
|
Walloon Region Government [Member] | Colorectal Cancer Research Agreement [Member] | In 2020 [Member] |
|
|
|
|
|
|
|
Amount payable |
|
|
|
|
|
$ 55,040
|
|
Terms of agreement description |
|
|
|
The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €278,830 and the 4.34% royalty on revenue, is equal to the amount of funding received
|
The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €278,830 and the 4.34% royalty on revenue, is equal to the amount of funding received
|
|
|
Repayment of grants | € |
|
|
|
€ 278,830
|
|
|
|
Grant receivable | € |
|
|
|
€ 929,433
|
|
|
|
Fixed interest rate on lease |
|
|
|
4.34%
|
|
4.34%
|
|
Walloon Region Government [Member] | Colorectal Cancer Research Agreement [Member] | In 2018 [Member] |
|
|
|
|
|
|
|
Amount payable |
|
|
|
|
|
$ 127,215
|
|
Terms of agreement description |
|
|
|
The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €181,500 and the 3.53% royalty on revenue, is equal to the amount of funding received.
|
The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €181,500 and the 3.53% royalty on revenue, is equal to the amount of funding received.
|
|
|
Repayment of grants | € |
|
|
|
€ 181,500
|
|
|
|
Grant receivable | € |
|
|
|
€ 605,000
|
|
|
|
ING [Member] | In 2016 [Member] | Long-term Debt [Member] |
|
|
|
|
|
|
|
Fixed interest rate on lease |
|
|
|
2.62%
|
|
2.62%
|
|
Lease payable |
|
|
|
|
|
$ 606,213
|
|
Purchase price for the property | € |
|
|
|
€ 1,120,000
|
|
|
|
DKFZ [Member] | In 2016 [Member] | Research Co-operation Agreement [Member] |
|
|
|
|
|
|
|
Collaborative obligations amount due |
|
|
|
|
|
237,029
|
|
Lease agreement expire period |
|
|
|
5 years
|
5 years
|
|
|
Collaborative obligations amount | € |
|
|
|
€ 400,000
|
|
|
|
University of Taiwan [Member] | In 2018 [Member] | Clinical Study Research Agreement [Member] |
|
|
|
|
|
|
|
Collaborative obligations amount due |
|
|
|
|
|
510,000
|
|
Lease agreement expire period |
|
|
|
3 years
|
3 years
|
|
|
Collaborative obligations amount |
|
|
|
|
|
2,550,000
|
|
Managing Director's Agreement [Member] |
|
|
|
|
|
|
|
Amount payable |
|
|
|
|
|
$ 229
|
|
Royalty payment |
|
|
|
|
$ 85,330
|
|
|
Royality |
|
|
|
6.00%
|
6.00%
|
|
|
Stock based compensation expenses |
|
|
|
|
$ 753,000
|
|
|
Managing Director's Agreement [Member] | Founder [Member] |
|
|
|
|
|
|
|
Fixed interest rate |
|
|
|
6.00%
|
|
6.00%
|
|
Repayment of long-term loan amount | € |
|
|
|
€ 8,000
|
|
|
|
Loan Agreement [Member] | ING [Member] | In 2016 [Member] | Long-term Debt [Member] |
|
|
|
|
|
|
|
Fixed interest rate |
|
|
|
2.62%
|
|
2.62%
|
|
Repayment of long-term loan amount | € |
|
|
|
€ 270,000
|
|
|
|
Total long-term debt |
|
|
|
|
|
$ 8,224
|
|
Loan agreement term |
|
|
|
15 years
|
15 years
|
|
|
Loan Agreement [Member] | Namur [Member] | October 13, 2020 [Member] | Long-term Debt [Member] |
|
|
|
|
|
|
|
Fixed interest rate |
|
|
|
4.00%
|
|
4.00%
|
|
Repayment of long-term loan amount | € |
|
|
|
€ 830,000
|
|
|
|
Maturity date |
|
|
|
March 2031
|
March 2031
|
|
|
Total long-term debt |
|
|
|
|
|
$ 963,562
|
|
Loan agreement term |
|
|
|
10 years
|
10 years
|
|
|
Loan Agreement [Member] | Namur Invest [Member] | In 2016 [Member] | Long-term Debt [Member] |
|
|
|
|
|
|
|
Fixed interest rate |
|
|
|
4.85%
|
|
4.85%
|
|
Repayment of long-term loan amount | € |
|
|
|
€ 440,000
|
|
|
|
Maturity date |
|
|
|
December 2031
|
December 2031
|
|
|
Total long-term debt |
|
|
|
|
|
$ 220,175
|
|
Loan agreement term |
|
|
|
7 years
|
7 years
|
|
|
Loan Agreement [Member] | Namur Invest [Member] | In 2019 [Member] | Long-term Debt [Member] |
|
|
|
|
|
|
|
Fixed interest rate |
|
|
|
4.80%
|
|
4.80%
|
|
Repayment of long-term loan amount | € |
|
|
|
€ 500,000
|
|
|
|
Maturity date |
|
|
|
September 2024
|
September 2024
|
|
|
Total long-term debt |
|
|
|
|
|
$ 553,460
|
|
Loan agreement term |
|
|
|
4 years
|
4 years
|
|
|
Loan Agreement [Member] | Namur Invest [Member] | In 2017 [Member] | Long-term Debt [Member] |
|
|
|
|
|
|
|
Fixed interest rate |
|
|
|
4.00%
|
|
4.00%
|
|
Repayment of long-term loan amount | € |
|
|
|
€ 350,000
|
|
|
|
Maturity date |
|
|
|
June 2021
|
June 2021
|
|
|
Total long-term debt |
|
|
|
|
|
$ 0
|
|
Loan agreement term |
|
|
|
4 years
|
4 years
|
|
|
Loan Agreement [Member] | SOFINEX [Member] | In 2017 [Member] | Long-term Debt [Member] |
|
|
|
|
|
|
|
Fixed interest rate |
|
|
|
4.50%
|
|
4.50%
|
|
Repayment of long-term loan amount | € |
|
|
|
€ 1,000,000
|
|
|
|
Maturity date |
|
|
|
September 2024
|
September 2024
|
|
|
Total long-term debt |
|
|
|
|
|
$ 888,857
|
|
Loan agreement term |
|
|
|
7 years
|
7 years
|
|
|
Bioinformatic Analytics Of Cell Free DNA [Member] | On September 16, 2020 [Member] |
|
|
|
|
|
|
|
Repayment of long-term loan amount | € |
|
|
|
€ 54,879
|
|
|
|
Total long-term debt |
|
|
|
|
|
94,947
|
|
Additional cost of company |
|
|
|
|
$ 155,115
|
|
|
TAMU [Member] | October 25, 2019 [Member] |
|
|
|
|
|
|
|
Non-controlling interest |
|
|
|
7.50%
|
7.50%
|
|
|
Equity interest |
|
|
|
12.50%
|
12.50%
|
|
|
Additional interest |
|
|
|
5.00%
|
5.00%
|
|
|
Operating Lease Right of Use Obligations [Member] |
|
|
|
|
|
|
|
Short term lease costs |
|
|
|
|
$ 323,996
|
|
|
Operating lease right-of-use assets |
|
|
|
|
|
$ 318,393
|
|
Weighted average discount rate |
|
|
|
4.49%
|
|
4.49%
|
|
Weighted average remaining lease term |
|
|
|
33 months
|
33 months
|
|
|
Payment of lease liabilities |
|
|
|
|
$ 44,059
|
|
|
Operating lease expense |
|
|
|
|
$ 44,355
|
|
|
Namur Innovation and Growth [Member] | Loan Agreement [Member] | In 2018 [Member] | Long-term Debt [Member] |
|
|
|
|
|
|
|
Fixed interest rate |
|
|
|
4.00%
|
|
4.00%
|
|
Repayment of long-term loan amount | € |
|
|
|
€ 500,000
|
|
|
|
Maturity date |
|
|
|
June 2022
|
June 2022
|
|
|
Total long-term debt |
|
|
|
|
|
$ 177,839
|
|
Loan agreement term |
|
|
|
4 years
|
4 years
|
|
|